Risk factors
Ardelyx (ARDX) risk factors
Item 1A of every Ardelyx, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors44 risks8 new10 dropped11 reworded
Manufacturing resilience becomes more prominent, including CMO compliance, single-source supply, capacity, tariffs and disaster recovery.
Filed Feb 19, 2026 - FY2024 10-K risk factors46 risks
Ardelyx faces heavy concentration risk around the commercial success of its only two products, IBSRELA and XPHOZAH. Medicare coverage changes for XPHOZAH under the ESRD PPS threaten future revenues. Operations depend heavily on single-source contract manufacturers.
Filed Feb 20, 2025